Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evaxion Biotech A/S ADR (NQ: EVAX )

3.140 +0.090 (+2.95%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,212
Open 3.200
Bid (Size) 3.050 (1)
Ask (Size) 3.500 (1)
Prev. Close 3.050
Today's Range 3.120 - 3.260
52wk Range 2.260 - 13.61
Shares Outstanding 37,897,780
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q2 2024
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
From Evaxion Biotech
Via GlobeNewswire

Performance

YTD
-56.99%
-56.99%
1 Month
+6.00%
+6.00%
3 Month
-22.28%
-22.28%
6 Month
-16.93%
-16.93%
1 Year
-66.80%
-66.80%

More News

Read More
iAccess Alpha's Buyside Best Ideas Virtual Summer Conference June 25-26, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Recap: Evaxion Biotech Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Evaxion Announces Business Update and First Quarter 2024 Financial Results
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
From Evaxion Biotech
Via GlobeNewswire
EVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023
Via InvestorPlace
Evaxion Announces Business Update and Full Year 2023 Financial Results
From Evaxion Biotech
Via GlobeNewswire
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
From Evaxion Biotech
Via GlobeNewswire
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
From Evaxion Biotech
Via GlobeNewswire
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
From Evaxion Biotech
Via GlobeNewswire
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Evaxion Biotech
Via GlobeNewswire
Evaxion Announces Closing of $15 Million Public Offering
From Evaxion Biotech
Via GlobeNewswire
Evaxion Biotech Announces Pricing of $15 Million Public Offering
From Evaxion Biotech
Via GlobeNewswire
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Edges Lower; US Composite PMI Rises In January
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.